u/aksel_kjaer
Contributes reviews on supplier material. Based in Ghent.
member · joined 12 Mar 2025
comment on TB-500 and Thymosin Beta-4 are not the same product and vendors know that in c/researchpeptides · 17 points · 3 days ago
Asked WXT which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
comment on [Lab] sequence check before price check. every time. in c/researchpeptides · 15 points · 4 days ago
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
comment on [Correction] you cannot report area% to two decimals off that baseline in c/hplc · 14 points · 7 days ago
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
comment on [Discussion] "tirz is stronger than sema" needs a comparator dose or it means nothing in c/tirzepatide · 13 points · 8 days ago
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
comment on [Paper] ACHIEVE-1 glycaemic data vs the injectables in c/orforglipron · 18 points · 10 days ago
oral semaglutide is a peptide with an absorption enhancer, this is not that
comment on the nausea profile at 7.5 was worse than 10 for me and i cannot explain it in c/tirzepatide · 55 points · 12 days ago
Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.
comment on anyone else find 15mg genuinely unpleasant with no extra loss in c/tirzepatide · 13 points · 19 days ago
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
comment on compounded tirz pricing has doubled in my area in four months in c/tirzepatide · 197 points · 22 days ago
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
comment on [Results] 65 weeks on 15mg, full numbers, ask me anything boring in c/tirzepatide · 13 points · 1 months ago
week 7 is early to draw any conclusion at all
comment on [PSA] HPLC is not what most of this community thinks it is in c/hplc · 9 points · 1 months ago
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
comment on the method development thing finally clicked for me and I want to write it down in c/hplc · 12 points · 1 months ago
axis labels or the trace is decoration
comment on three years of small molecule threads, summarised so you do not have to read them in c/orforglipron · 40 points · 2 months ago
a non-peptide agonist does not degrade the way a peptide does
comment on unpopular opinion: most of what gets said here about HPLC is guesswork in c/hplc · 39 points · 2 months ago
reproducibility beats resolution if you only get one of them
comment on [Lab] split one vial across Medutest and Janoshik — 99.3% and 98.7% in c/tirzepatide · 19 points · 2 months ago
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
comment on the gradient question that gets asked weekly, answered properly in c/hplc · 29 points · 2 months ago
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
comment on why does nobody talk about non-peptide in c/orforglipron · 4 points · 2 months ago
Careful — purity methods for peptides do not read across to a small molecule and the numbers are not equivalent.
comment on help me understand integration, I have read the wiki twice in c/hplc · 1 points · 3 months ago
Can you post the trace with the axes labelled?
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
comment on does DEXA actually matter or is it forum lore at this point in c/glp1muscle · 2 points · 3 months ago
Yes. Lean mass change during weight loss is expected; the useful question is the proportion, not whether it happens.
comment on help me understand sarcopenia, I have read the wiki twice in c/glp1muscle · 129 points · 4 months ago
Agreed on the error margin. Quoting a DEXA to one decimal implies a precision the method does not have.
comment on [PSA] Zepbound is not what most of this community thinks it is in c/tirzepatide · 1 points · 4 months ago
30kg over 69 weeks, never went past 10mg, and fatigue stayed mild the whole way. Posting because the loud threads are all 15mg.
comment on genuine question about chromatogram that I am slightly embarrassed to ask in c/hplc · 1 points · 5 months ago
What wavelength, and what was the gradient?
comment on [Meta] proposal — a flair for HPLC posts in c/hplc · 162 points · 6 months ago
Same view — reporting the gradient is what makes a result checkable rather than merely stated.
comment on how much of what we believe about TB-500 actually comes from research peptides threads in c/researchpeptides · 61 points · 6 months ago
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
comment on my ferritin moved and I cannot work out whether non-peptide is why in c/orforglipron · 212 points · 6 months ago
do not assume reconstitution intuitions apply, there is nothing to reconstitute
comment on [Question] gradient — what am I missing here in c/hplc · 29 points · 7 months ago
a shoulder is not an impurity until you can resolve it
comment on [Lab] MKM cagri — Medutest came back 97.7% against a claimed 97.0% in c/hplc · 246 points · 7 months ago
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
comment on am I the only one who found resistance training harder than the injections in c/glp1muscle · 124 points · 8 months ago
strength retention is a decent proxy and it is free
comment on reading gradient threads from 2024 and half of it aged badly in c/hplc · 155 points · 8 months ago
integration decisions move the number more than the sample does
ewan_zielinski is right — the integration choice is a decision and it should be stated alongside the result.
comment on [Lab] 8th independent test on QST — 98.6% on a claimed 98.5%, and the trend is the interesting part in c/tirzepatide · 20 points · 9 months ago
Did you come to this from sema, and if so how long was the gap?
comment on [Lab] 8th independent test on QST — 98.6% on a claimed 98.5%, and the trend is the interesting part in c/tirzepatide · 1 points · 9 months ago
Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.
comment on how much of what we believe about integration actually comes from LC-MS threads in c/hplc · 1 points · 9 months ago
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
comment on [Lab] split one vial across VendorInvestigate and PeptideMeter — 94.2% and 96.8% in c/researchpeptides · 57 points · 9 months ago
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
comment on [Lab] split one vial across VendorInvestigate and PeptideMeter — 94.2% and 96.8% in c/researchpeptides · 461 points · 9 months ago
Correction: that name covers two different molecules and the thread has been discussing both as one.
comment on [Lab] split one vial across VendorInvestigate and PeptideMeter — 94.2% and 96.8% in c/researchpeptides · -18 points · 9 months ago
Has anyone here tested that compound at all?
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · 1 points · 9 months ago
nothing containing this is approved anywhere and research material is not for human use
comment on small win: Mounjaro stopped being a problem at week 66 in c/tirzepatide · 54 points · 10 months ago
switching from sema is not a dose conversion, there is no clean equivalence
comment on small win: Mounjaro stopped being a problem at week 66 in c/tirzepatide · 166 points · 10 months ago
Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.
comment on oral GLP-1 — 12 things I got wrong before I got it right in c/orforglipron · 3 points · 10 months ago
Push back: daily dosing is not automatically better adherence. It is a different failure mode, not a solved problem.
comment on the GIP question that gets asked weekly, answered properly in c/tirzepatide · 219 points · 11 months ago
Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.
comment on [Question] TB-500 — what am I missing here in c/researchpeptides · 11 points · 11 months ago
Right — GL Biochem answered a handling question with actual storage conditions rather than a generic line, which is the standard.